The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy

Muwen Yang1 Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, [email protected]

Xingsong Qin1 Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, [email protected]

Guangyuan Qin2 Breast Cancer Institute of the First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, [email protected]

Xinyu Zheng1 Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, [email protected];2 Breast Cancer Institute of the First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China, [email protected]Correspondence[email protected]

Pages 2171-2180 | Published online: 25 Mar 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
PubMed Web of Science ®Google Scholar
BartschRZiebermayrRZielinskiCCStegerGGTriple-negative breast cancerWien Med Wochenschr20101607–817418120473728
PubMedGoogle Scholar
ZardavasDPiccartMNeoadjuvant therapy for breast cancerAnnu Rev Med201566314825386936
PubMed Web of Science ®Google Scholar
MamounasEPImpact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancerAnn Surg Oncol20152251425143325727558
PubMed Web of Science ®Google Scholar
RapoportBLDemetriouGSMoodleySDBennCAWhen and how do I use neoadjuvant chemotherapy for breast cancer?Curr Treat Options Oncol2014151869824306808
PubMed Web of Science ®Google Scholar
ReddenMHFuhrmanGMNeoadjuvant chemotherapy in the treatment of breast cancerSurg Clin N Am201393249349923464698
PubMed Web of Science ®Google Scholar
KaufmannMvon MinckwitzGMamounasEPRecommendations from an international consensus Conference on the current status and future of neoadjuvant systemic therapy in primary breast cancerAnn Surg Oncol20121951508151622193884
PubMed Web of Science ®Google Scholar
JanssensSBeyaertRFunctional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family membersMolecular Cell200311229330212620219
PubMed Web of Science ®Google Scholar
ZhuJMohanCToll-like receptor signaling pathways-therapeutic opportunitiesMediators Inflamm2010201078123520981241
PubMed Web of Science ®Google Scholar
SrivastavaRGengDLiuYAugmentation of therapeutic responses in melanoma by inhibition of IRAK-1, -4Cancer Res201272236209621623041547
PubMed Web of Science ®Google Scholar
ChengBYLauEYLeungHWIRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinomaCancer Res20187892332234229483095
PubMed Web of Science ®Google Scholar
ChouCKChiSYHuangCHIRAK1, a target of miR-146b, reduces cell aggressiveness of human papillary thyroid carcinomaJ Clin Endocrinol Metab2016101114357436627533309
PubMed Web of Science ®Google Scholar
ZhangXDangYLiPRongMChenGExpression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray studyInt J Clin Exp Pathol20147118096810425550857
PubMed Web of Science ®Google Scholar
PilarskyCWenzigMSpechtTSaegerHDGrützmannRIdentification and validation of commonly overexpressed genes in solid tumors by comparison of microarray dataNeoplasia20046674475015720800
PubMed Web of Science ®Google Scholar
WeeZNYatimSMKohlbauerVKIRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxelNat Commun201561874626503059
PubMedGoogle Scholar
NenutilRA revolution postponed indefinitely. WHO classification of tumors of the breast 2012: the main changes compared to the 3rd edition (2003)Cesk Patol2015511232525671358
PubMedGoogle Scholar
YuNYHallströmBMFagerbergLFantom ConsortiumComplementing tissue characterization by integrating transcriptome profiling from the human protein Atlas and from the FANTOM5 ConsortiumNucleic Acids Res201543146787679826117540
PubMed Web of Science ®Google Scholar
CeramiEGaoJDogrusozUThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataCancer Discov20122540140422588877
PubMed Web of Science ®Google Scholar
SirintrapunSJZehirASyedAGaoJSchultzNChengDTTranslational bioinformatics and clinical research (biomedical) informaticsClin Lab Med201636115318126851671
PubMed Web of Science ®Google Scholar
BelizárioJESangiulianoBAPerez-SosaMNeyraJMMoreiraDFUsing pharmacogenomic databases for discovering Patient-Target genes and small molecule candidates to cancer therapyFront Pharmacol2016731227746730
PubMed Web of Science ®Google Scholar
SzklarczykDFranceschiniAKuhnMThe string database in 2011: functional interaction networks of proteins, globally integrated and scoredNucleic Acids Res201139Database issueD561D56821045058
PubMed Web of Science ®Google Scholar
SzklarczykDFranceschiniAWyderSString v10: protein-protein interaction networks, integrated over the tree of lifeNucleic Acids Res201543Database issueD447D45225352553
PubMed Web of Science ®Google Scholar
TangZLiCKangBGaoGLiCZhangZGEPIA: a web server for cancer and normal gene expression profiling and interactive analysesNucleic Acids Res201745W1W98W10228407145
PubMed Web of Science ®Google Scholar
ZhangBKirovSSnoddyJWebGestalt: an integrated system for exploring gene sets in various biological contextsNucleic Acids Research200533Web Server issueW741W74815980575
PubMed Web of Science ®Google Scholar
WangJDuncanDShiZZhangBWeb-based gene set analysis toolkit (WebGestalt): update 2013Nucleic Acids Res201341Web server issueW77W8323703215
PubMed Web of Science ®Google Scholar
WestACTangKTyeHIdentification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancerOncogene201736365134514428481875
PubMed Web of Science ®Google Scholar
ScheerenFAKuoAHvan WeeleLJA cell-intrinsic role for TLR2–MYD88 in intestinal and breast epithelia and oncogenesisNat Cell Biol201416121238124825362351
PubMed Web of Science ®Google Scholar
RajputSVolk-DraperLDRanSTLR4 is a novel determinant of the response to paclitaxel in breast cancerMol Cancer Ther20131281676168723720768
PubMed Web of Science ®Google Scholar
RhyasenGWBolanosLFangJTargeting IRAK1 as a therapeutic approach for myelodysplastic syndromeCancer Cell20132419010423845443
PubMed Web of Science ®Google Scholar
YeZHGaoLWenDYDiagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlasOnco Targets Ther2017101711172328356759
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date